Pub Date : 2025-09-19DOI: 10.1016/j.jogc.2025.103131
Sandra I. Dunn RN, BNSc, MEd, MScN, PhD , Yanfang Guo MSc, MB, PhD , Sheryll Dimanlig-Cruz MSc , Malia S.Q. Murphy PhD , Sara Carolina Scremin Souza MSc , Ruth Rennicks White RN, BScN , Deshayne B. Fell MSc, PhD , Shi Wu Wen PhD , Jun Zhang PhD , Mark C. Walker MD, MSc, MSCHM , Darine El-Chaâr MD, MSc
Objectives
This study aimed to describe the trends in cesarean delivery (CD) rates in Ontario using the modified Robson classification system, and identify the most common indications for CD.
Methods
We conducted a population-based retrospective cross-sectional study using data from the Better Outcomes Registry & Network, a comprehensive maternal-child registry in Ontario. The analysis included all pregnant persons who delivered a live- or stillborn infant weighing ≥500 g at ≥200 weeks gestation between April 1, 2012 and March 31, 2019.
Results
A total of 952 567 pregnant persons gave birth in Ontario, Canada, during the study period. Our findings demonstrated a slight increase in the overall CD rate over 7 fiscal years from 2012–2013 to 2018–2019. Robson group 5 (term, singleton, cephalic pregnancy with previous CD), groups 1 and 2 (nulliparous, term, singleton, cephalic pregnancy and no labour, induced labour, or spontaneous labour), and group 6 (nulliparous pregnancy with breech presentation) made the largest contributions to the overall CD rate over the study period. The top 5 primary indications for CD across all years included previous CD, atypical or abnormal fetal surveillance, malposition/malpresentation, non-progressive first stage of labour, and non-progressive second stage of labour.
Conclusions
The results enhance our understanding of the key drivers of CD rates. These findings will help to inform practice improvement, support policy change, and identify areas where future research is needed.
{"title":"Evaluation of Cesarean Delivery Rates across Ontario from 2012 to 2019 Using the Modified Robson Classification System: A Population-Based Study","authors":"Sandra I. Dunn RN, BNSc, MEd, MScN, PhD , Yanfang Guo MSc, MB, PhD , Sheryll Dimanlig-Cruz MSc , Malia S.Q. Murphy PhD , Sara Carolina Scremin Souza MSc , Ruth Rennicks White RN, BScN , Deshayne B. Fell MSc, PhD , Shi Wu Wen PhD , Jun Zhang PhD , Mark C. Walker MD, MSc, MSCHM , Darine El-Chaâr MD, MSc","doi":"10.1016/j.jogc.2025.103131","DOIUrl":"10.1016/j.jogc.2025.103131","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to describe the trends in cesarean delivery (CD) rates in Ontario using the modified Robson classification system, and identify the most common indications for CD.</div></div><div><h3>Methods</h3><div>We conducted a population-based retrospective cross-sectional study using data from the Better Outcomes Registry & Network, a comprehensive maternal-child registry in Ontario. The analysis included all pregnant persons who delivered a live- or stillborn infant weighing ≥500 g at ≥20<sup>0</sup> weeks gestation between April 1, 2012 and March 31, 2019.</div></div><div><h3>Results</h3><div>A total of 952 567 pregnant persons gave birth in Ontario, Canada, during the study period. Our findings demonstrated a slight increase in the overall CD rate over 7 fiscal years from 2012–2013 to 2018–2019. Robson group 5 (term, singleton, cephalic pregnancy with previous CD), groups 1 and 2 (nulliparous, term, singleton, cephalic pregnancy and no labour, induced labour, or spontaneous labour), and group 6 (nulliparous pregnancy with breech presentation) made the largest contributions to the overall CD rate over the study period. The top 5 primary indications for CD across all years included previous CD, atypical or abnormal fetal surveillance, malposition/malpresentation, non-progressive first stage of labour, and non-progressive second stage of labour.</div></div><div><h3>Conclusions</h3><div>The results enhance our understanding of the key drivers of CD rates. These findings will help to inform practice improvement, support policy change, and identify areas where future research is needed.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 12","pages":"Article 103131"},"PeriodicalIF":2.2,"publicationDate":"2025-09-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145115908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-18DOI: 10.1016/j.jogc.2025.103124
Anjelica Hodgson MD , Kathy Han MD, MSc , Stephen Welch MD , Wendy R. Parulekar MD , Jessica N. McAlpine MD , Mary Kinloch MD
Molecular classification of endometrial carcinoma provides important prognostic and predictive information and ongoing clinical trials are investigating different treatment paradigms and therapy de-escalation. Despite its benefits, there is variability in the application of molecular classification worldwide, including in Canada. A digital survey was distributed to gynaecologic pathologists in 13 Canadian academic pathology departments, and areas of homogeneity and variability in practice for endometrial carcinoma molecular classification were identified. Perceived barriers to universal application included resource restrictions and ambiguity of management implications. Focused research, knowledge translation, and guideline development will aid in more consistent implementation/application.
{"title":"Endometrial Carcinoma Molecular Classification and Barriers to Implementation, Possible Solutions, and the Implications for Ongoing Clinical Trials","authors":"Anjelica Hodgson MD , Kathy Han MD, MSc , Stephen Welch MD , Wendy R. Parulekar MD , Jessica N. McAlpine MD , Mary Kinloch MD","doi":"10.1016/j.jogc.2025.103124","DOIUrl":"10.1016/j.jogc.2025.103124","url":null,"abstract":"<div><div>Molecular classification of endometrial carcinoma provides important prognostic and predictive information and ongoing clinical trials are investigating different treatment paradigms and therapy de-escalation. Despite its benefits, there is variability in the application of molecular classification worldwide, including in Canada. A digital survey was distributed to gynaecologic pathologists in 13 Canadian academic pathology departments, and areas of homogeneity and variability in practice for endometrial carcinoma molecular classification were identified. Perceived barriers to universal application included resource restrictions and ambiguity of management implications. Focused research, knowledge translation, and guideline development will aid in more consistent implementation/application.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103124"},"PeriodicalIF":2.2,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102784","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-18DOI: 10.1016/j.jogc.2025.103125
Lara Des Roches MD, MSc, BScN, Bianca Ziegler MD, MSc, BHSc, Stacy Deniz MD
Objective
This study aimed to ascertain trans peoples’ interest in reproductive choices. Our secondary objective was to understand barriers to meeting their reproductive goals.
Methods
We conducted a descriptive cross-sectional study using a one-time anonymous survey. Analysis was conducted using descriptive statistics and a thematic analysis using inductive coding.
Results
Analysis of trans participants’ responses revealed 82% (N = 169) of participants are interested in pursuing reproductive options (biologically related children, donor gametes, gestational carriers, or fertility preservation). Sixty-eight percent (N = 172) of participants are taking gender-affirming hormone therapy or plan to start. Forty-nine percent (N = 124) have had or plan to have gender-affirming surgery that affects fertility. Trans folks experience many barriers when accessing fertility care; cost and trans-specific barriers were the most common and insurmountable barriers.
Conclusions
Our study highlights that trans folks are interested in reproductive options. However, many trans people experience significant barriers to meeting their reproductive goals and this significantly impacts their quality of life. With most of our survey population identifying as trans at an age during the window of peak fertility, we highlight the importance of early assessment and treatment to achieve fertility goals.
{"title":"Trans Peoples’ Interest in Reproduction and Fertility Preservation: A Cross-Sectional, Descriptive Study Into Barriers to Reproductive Care","authors":"Lara Des Roches MD, MSc, BScN, Bianca Ziegler MD, MSc, BHSc, Stacy Deniz MD","doi":"10.1016/j.jogc.2025.103125","DOIUrl":"10.1016/j.jogc.2025.103125","url":null,"abstract":"<div><h3>Objective</h3><div>This study aimed to ascertain trans peoples’ interest in reproductive choices. Our secondary objective was to understand barriers to meeting their reproductive goals.</div></div><div><h3>Methods</h3><div>We conducted a descriptive cross-sectional study using a one-time anonymous survey. Analysis was conducted using descriptive statistics and a thematic analysis using inductive coding.</div></div><div><h3>Results</h3><div>Analysis of trans participants’ responses revealed 82% (N = 169) of participants are interested in pursuing reproductive options (biologically related children, donor gametes, gestational carriers, or fertility preservation). Sixty-eight percent (N = 172) of participants are taking gender-affirming hormone therapy or plan to start. Forty-nine percent (N = 124) have had or plan to have gender-affirming surgery that affects fertility. Trans folks experience many barriers when accessing fertility care; cost and trans-specific barriers were the most common and insurmountable barriers.</div></div><div><h3>Conclusions</h3><div>Our study highlights that trans folks are interested in reproductive options. However, many trans people experience significant barriers to meeting their reproductive goals and this significantly impacts their quality of life. With most of our survey population identifying as trans at an age during the window of peak fertility, we highlight the importance of early assessment and treatment to achieve fertility goals.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 12","pages":"Article 103125"},"PeriodicalIF":2.2,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103088","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-18DOI: 10.1016/j.jogc.2025.103127
Atar Ben Shmuel MD , Nikola Rasevic MSc , Howard Berger MD , Elad Mei-Dan MD , Jon Barrett MD , Nir Melamed MSc, MD , Amir Aviram MD
Objectives
We aimed to explore how the COVID-19 pandemic impacted the incidence of preterm birth (PTB) and other perinatal outcomes.
Methods
This is a population-based cohort study using provincial-level population data. The study population consisted of persons who gave birth in a setting of a single-payer insurer during the period from January 2020 to December 2020. The comparator group included persons who delivered in the same setting between January 2017 and December 2019. The main outcome measured was PTB before 37 weeks gestation. In addition, we analyzed several secondary outcomes, including PTB at different gestational ages, hypertensive disorders in pregnancy, and composite neonatal morbidity (5-minute Apgar score <5, respiratory distress syndrome, or need for mechanical ventilation).
Results
Between January 2020 and December 2020, 116 244 births were documented (study group) and were compared with 363 650 births that occurred between January 2017 and December 2019 (control group). There was no difference in the rate of PTB before 37 weeks (7.57% vs. 7.57%, adjusted relative risk [aRR] 1.00, 95% CI 0.98–1.02), nor were there differences in the rate of PTB before 34, 32, 28, or 26 weeks gestation. The risk for gestational diabetes was slightly higher (9.54% vs. 8.67%, aRR 1.07, 95% CI 1.05–1.10), as was the risk of composite neonatal morbidity (11.65% vs. 10.85%, aRR 1.06, 95% CI 1.04–1.08).
Conclusions
During the first year of the COVID-19 pandemic, the rate of PTB was not higher than in previous years. However, a higher risk of gestational diabetes and composite neonatal morbidity was noted.
目的:探讨新冠肺炎大流行对早产儿及其他围产期结局的影响。方法:采用基于人群的队列研究,使用省级人口数据。研究人群包括在2020年1月至2020年12月期间在单一付款人保险公司的环境中分娩的个人。比较组包括在2017年1月至2019年12月期间在相同环境中分娩的个体。测量的主要结果是妊娠37周前的早产(PTB)。此外,我们分析了几个次要结局,包括不同胎龄的PTB、妊娠期高血压疾病和新生儿综合发病率(5分钟Apgar评分)。结果:2020年1月至2020年12月,记录了116 244例新生儿(研究组),并与2017年1月至2019年12月(对照组)的363 650例新生儿进行了比较。37周之前的PTB发病率没有差异(7.57% vs. 7.57%, aRR 1.00, 95% CI 0.98-1.02),妊娠34、32、28或26周之前的PTB发病率也没有差异。妊娠期糖尿病的风险略高(9.54%对8.67%,aRR 1.07, 95% CI 1.05-1.10),新生儿复合发病率的风险也略高(11.65%对10.85%,aRR 1.06, 95% CI 1.04-1.08)。结论:2019冠状病毒病大流行第一年的早产率不高于前几年。但是,注意到妊娠期糖尿病和新生儿综合发病率的风险较高。
{"title":"Health Care System Burden During the COVID-19 Pandemic and Pregnancy Outcomes: A Population-Based Study","authors":"Atar Ben Shmuel MD , Nikola Rasevic MSc , Howard Berger MD , Elad Mei-Dan MD , Jon Barrett MD , Nir Melamed MSc, MD , Amir Aviram MD","doi":"10.1016/j.jogc.2025.103127","DOIUrl":"10.1016/j.jogc.2025.103127","url":null,"abstract":"<div><h3>Objectives</h3><div>We aimed to explore how the COVID-19 pandemic impacted the incidence of preterm birth (PTB) and other perinatal outcomes.</div></div><div><h3>Methods</h3><div>This is a population-based cohort study using provincial-level population data. The study population consisted of persons who gave birth in a setting of a single-payer insurer during the period from January 2020 to December 2020. The comparator group included persons who delivered in the same setting between January 2017 and December 2019. The main outcome measured was PTB before 37 weeks gestation. In addition, we analyzed several secondary outcomes, including PTB at different gestational ages, hypertensive disorders in pregnancy, and composite neonatal morbidity (5-minute Apgar score <5, respiratory distress syndrome, or need for mechanical ventilation).</div></div><div><h3>Results</h3><div>Between January 2020 and December 2020, 116 244 births were documented (study group) and were compared with 363 650 births that occurred between January 2017 and December 2019 (control group). There was no difference in the rate of PTB before 37 weeks (7.57% vs. 7.57%, adjusted relative risk [aRR] 1.00, 95% CI 0.98–1.02), nor were there differences in the rate of PTB before 34, 32, 28, or 26 weeks gestation. The risk for gestational diabetes was slightly higher (9.54% vs. 8.67%, aRR 1.07, 95% CI 1.05–1.10), as was the risk of composite neonatal morbidity (11.65% vs. 10.85%, aRR 1.06, 95% CI 1.04–1.08).</div></div><div><h3>Conclusions</h3><div>During the first year of the COVID-19 pandemic, the rate of PTB was not higher than in previous years. However, a higher risk of gestational diabetes and composite neonatal morbidity was noted.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103127"},"PeriodicalIF":2.2,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145102880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-18DOI: 10.1016/j.jogc.2025.103126
Thi Thu Lieu Nguyen MD , Thu Huyen Doan BSc , Kieu Trang Ha BSc , Hien Anh Le BSc , Thi Tu Anh Tran BSc , Thi Thanh Xuan Le PhD , Thi Van Anh Nguyen MSc , Thi Huong Le PhD , Thi My Thuc Luu PhD
Objectives
The Screening for Obstetric Undernutrition in Pregnancy Detection (SOUND-P) is a questionnaire designed to assess the nutrition status of hospitalized pregnant women. The aim of this study was to evaluate the validity and reliability of the SOUND-P among inpatients.
Methods
A total of 200 pregnant women were admitted to the National Hospital of Obstetrics and Gynecology, Vietnam from November 2023 to January 2024. Nutritional risk screened by SOUND-P was compared with the International Federation of Gynecology and Obstetrics Nutrition Checklist, the obstetric nutritional risk screening, composite diagnostic criteria, and estimated fetal weight. We determined sensitivity, specificity, positive predictive values, negative predictive values, receiver operator characteristics curve, and the best cut-off scores. Inter-rater reliability was assessed using κ measurements.
Results
Using SOUND-P, the optimal cut-off score to identify malnourished pregnant women was 1, with 62.5% of patients at risk of malnutrition. The percentage agreement between dietitian and nurse was 98.0%, with a κ value of 0.96 (95% CI 0.94–1.00). SOUND-P demonstrated sensitivity ranging from 80.65% to 90.70%, specificity ranging from 40.11% to 45.22%, positive predictive values from 12.80% to 31.20%, and negative predictive values from 92.00% to 97.33%. The areas under the receiver operating characteristic curve for SOUND-P were above 0.6.
Conclusions
The SOUND-P is a valid and reliable nutrition screening tool for determining malnutrition risk in hospitalized pregnant women.
{"title":"Validation of a New Malnutrition Screening Tool for Hospitalized Pregnant Women","authors":"Thi Thu Lieu Nguyen MD , Thu Huyen Doan BSc , Kieu Trang Ha BSc , Hien Anh Le BSc , Thi Tu Anh Tran BSc , Thi Thanh Xuan Le PhD , Thi Van Anh Nguyen MSc , Thi Huong Le PhD , Thi My Thuc Luu PhD","doi":"10.1016/j.jogc.2025.103126","DOIUrl":"10.1016/j.jogc.2025.103126","url":null,"abstract":"<div><h3>Objectives</h3><div>The Screening for Obstetric Undernutrition in Pregnancy Detection (SOUND-P) is a questionnaire designed to assess the nutrition status of hospitalized pregnant women. The aim of this study was to evaluate the validity and reliability of the SOUND-P among inpatients.</div></div><div><h3>Methods</h3><div>A total of 200 pregnant women were admitted to the National Hospital of Obstetrics and Gynecology, Vietnam from November 2023 to January 2024. Nutritional risk screened by SOUND-P was compared with the International Federation of Gynecology and Obstetrics Nutrition Checklist, the obstetric nutritional risk screening, composite diagnostic criteria, and estimated fetal weight. We determined sensitivity, specificity, positive predictive values, negative predictive values, receiver operator characteristics curve, and the best cut-off scores. Inter-rater reliability was assessed using κ measurements.</div></div><div><h3>Results</h3><div>Using SOUND-P, the optimal cut-off score to identify malnourished pregnant women was 1, with 62.5% of patients at risk of malnutrition. The percentage agreement between dietitian and nurse was 98.0%, with a κ value of 0.96 (95% CI 0.94–1.00). SOUND-P demonstrated sensitivity ranging from 80.65% to 90.70%, specificity ranging from 40.11% to 45.22%, positive predictive values from 12.80% to 31.20%, and negative predictive values from 92.00% to 97.33%. The areas under the receiver operating characteristic curve for SOUND-P were above 0.6.</div></div><div><h3>Conclusions</h3><div>The SOUND-P is a valid and reliable nutrition screening tool for determining malnutrition risk in hospitalized pregnant women.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103126"},"PeriodicalIF":2.2,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145103051","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12DOI: 10.1016/j.jogc.2025.103109
Zi-yun Liao MD, Yu Chen MD, Zhenbo OuYang MD
{"title":"Umbilical Port Site Metastasis After Laparoscopic Radical Hysterectomy for Cervical Cancer","authors":"Zi-yun Liao MD, Yu Chen MD, Zhenbo OuYang MD","doi":"10.1016/j.jogc.2025.103109","DOIUrl":"10.1016/j.jogc.2025.103109","url":null,"abstract":"","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103109"},"PeriodicalIF":2.2,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145067558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-12DOI: 10.1016/j.jogc.2025.103112
Carolina Lavin Venegas BScN, MSc , Kasim E. Abdulaziz PhD , Joel G. Ray MD, MSc , Mark Walker MD, MSc, MSHCM , Janet Brownlee RN, MScN , Ann E. Sprague RN, PhD
Objectives
Obstetric hemorrhage is a leading cause of pregnancy-related death. This study examined the characteristics, subtypes, and timing of obstetrical hemorrhagic deaths within a universal health care system.
Methods
Secondary analysis of a retrospective cohort study of linked administrative data, in which 485 post-pregnancy deaths over a 20-year period were identified. Obstetric hemorrhage deaths within 365 days of birth were reviewed by at least 3 clinicians to determine the main cause and timing of death.
Results
Of 485 post-pregnancy deaths, 46 (9.5%) were attributed to obstetric hemorrhage, representing 27% of pregnancy-related deaths (46 of 169). All 46 obstetric hemorrhage deaths occurred within 12 days postpartum, with 26 deaths (56.5%) on the day of delivery. The top causes of fatal obstetrical hemorrhage were 9 (19.6%) amniotic fluid embolisms, 6 (13.0%) placental abruptions, and 5 (10.9%) uterine ruptures; but in 14 (30%) cases, the main cause was uncertain. Of all fatal hemorrhages, 3 (6.5%) began antepartum, 17 (37.0%) intrapartum, and 20 (43.5%) postpartum. Deaths were higher in more materially deprived neighbourhoods (39.1% in quintile 5 vs. 6.5% in quintile 1). Obstetric hemorrhage deaths were highest for Sunday deliveries (3.7 per 100 000 births, rate ratio 3.8; 95% CI 0.8–18.8), followed by Monday deliveries (2.7 per 100 000, rate ratio 2.7; 95% CI 0.5–13.9).
Conclusions
Obstetric hemorrhage remains a major contributor to pregnancy-related deaths, with most fatalities occurring very early postpartum. This study provides important insights into maternal post-pregnancy deaths due to obstetric hemorrhage in Ontario over a 20-year period.
{"title":"Fatal Obstetrical Hemorrhage: A 20-Year Analysis From Ontario","authors":"Carolina Lavin Venegas BScN, MSc , Kasim E. Abdulaziz PhD , Joel G. Ray MD, MSc , Mark Walker MD, MSc, MSHCM , Janet Brownlee RN, MScN , Ann E. Sprague RN, PhD","doi":"10.1016/j.jogc.2025.103112","DOIUrl":"10.1016/j.jogc.2025.103112","url":null,"abstract":"<div><h3>Objectives</h3><div>Obstetric hemorrhage is a leading cause of pregnancy-related death. This study examined the characteristics, subtypes, and timing of obstetrical hemorrhagic deaths within a universal health care system.</div></div><div><h3>Methods</h3><div>Secondary analysis of a retrospective cohort study of linked administrative data, in which 485 post-pregnancy deaths over a 20-year period were identified. Obstetric hemorrhage deaths within 365 days of birth were reviewed by at least 3 clinicians to determine the main cause and timing of death.</div></div><div><h3>Results</h3><div>Of 485 post-pregnancy deaths, 46 (9.5%) were attributed to obstetric hemorrhage, representing 27% of pregnancy-related deaths (46 of 169). All 46 obstetric hemorrhage deaths occurred within 12 days postpartum, with 26 deaths (56.5%) on the day of delivery. The top causes of fatal obstetrical hemorrhage were 9 (19.6%) amniotic fluid embolisms, 6 (13.0%) placental abruptions, and 5 (10.9%) uterine ruptures; but in 14 (30%) cases, the main cause was uncertain. Of all fatal hemorrhages, 3 (6.5%) began antepartum, 17 (37.0%) intrapartum, and 20 (43.5%) postpartum. Deaths were higher in more materially deprived neighbourhoods (39.1% in quintile 5 vs. 6.5% in quintile 1). Obstetric hemorrhage deaths were highest for Sunday deliveries (3.7 per 100 000 births, rate ratio 3.8; 95% CI 0.8–18.8), followed by Monday deliveries (2.7 per 100 000, rate ratio 2.7; 95% CI 0.5–13.9).</div></div><div><h3>Conclusions</h3><div>Obstetric hemorrhage remains a major contributor to pregnancy-related deaths, with most fatalities occurring very early postpartum. This study provides important insights into maternal post-pregnancy deaths due to obstetric hemorrhage in Ontario over a 20-year period.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103112"},"PeriodicalIF":2.2,"publicationDate":"2025-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145067473","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11DOI: 10.1016/j.jogc.2025.103120
Ernesto A. Figueiro-Filho MD, PhD, Genevieve Dietrich HBSc, MEng, Adrielle P. Souza Lira BSN, RN, Eman Ramadan MD, Adewumi Adanlawo MD, John Matelski MSc, Joshua D. Buse PhD
Objectives
This study aimed to evaluate the association between placental growth factor (PlGF) levels, ultrasound findings, and perinatal outcomes in a high-risk pregnant population at a tertiary referral centre in Western Canada, and to assess the predictive performance of the PlGF test.
Methods
We conducted a retrospective cohort study of 389 high-risk pregnant individuals who underwent PlGF testing between 120 and 360 weeks gestation. Participants were stratified by PlGF level: normal (≥10th centile), inconclusive (5th–9th centile), and low (≤5th centile). Clinical, biochemical, ultrasound, and perinatal outcomes were compared across groups. Odds ratios, sensitivity, specificity, and predictive values were calculated.
Results
Low PlGF levels were observed in 33.9% of pregnancies, with testing performed at a median gestational age of 276 weeks. Low PlGF levels were significantly associated with higher maternal BMI, elevated blood pressure, and increased creatinine, uric acid, and proteinuria levels. Ultrasound findings in the low PlGF group revealed higher rates of fetal growth restriction, abnormal Doppler studies, and abnormal placental morphology. These pregnancies had increased incidence of preterm birth <340 weeks (52/132; 39.3%), preeclampsia (69/132; 52.3%), neonatal intensive care unit admission (54/132; 40.9%), and small-for-gestational-age neonates (15/132; 11.4%). Most negative predictive values exceeded 90%.
Conclusions
Low maternal PlGF levels are strongly associated with ultrasound and biochemical indicators of placental dysfunction and adverse perinatal outcomes. PlGF testing may serve as an effective risk stratification tool in high-risk pregnancies, particularly in rural and underserved populations.
{"title":"Implementation of Placental Growth Factor in a Tertiary Western Canadian Centre: Association with Ultrasound Findings and Perinatal Outcomes","authors":"Ernesto A. Figueiro-Filho MD, PhD, Genevieve Dietrich HBSc, MEng, Adrielle P. Souza Lira BSN, RN, Eman Ramadan MD, Adewumi Adanlawo MD, John Matelski MSc, Joshua D. Buse PhD","doi":"10.1016/j.jogc.2025.103120","DOIUrl":"10.1016/j.jogc.2025.103120","url":null,"abstract":"<div><h3>Objectives</h3><div>This study aimed to evaluate the association between placental growth factor (PlGF) levels, ultrasound findings, and perinatal outcomes in a high-risk pregnant population at a tertiary referral centre in Western Canada, and to assess the predictive performance of the PlGF test.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of 389 high-risk pregnant individuals who underwent PlGF testing between 12<sup>0</sup> and 36<sup>0</sup> weeks gestation. Participants were stratified by PlGF level: normal (≥10th centile), inconclusive (5th–9th centile), and low (≤5th centile). Clinical, biochemical, ultrasound, and perinatal outcomes were compared across groups. Odds ratios, sensitivity, specificity, and predictive values were calculated.</div></div><div><h3>Results</h3><div>Low PlGF levels were observed in 33.9% of pregnancies, with testing performed at a median gestational age of 27<sup>6</sup> weeks. Low PlGF levels were significantly associated with higher maternal BMI, elevated blood pressure, and increased creatinine, uric acid, and proteinuria levels. Ultrasound findings in the low PlGF group revealed higher rates of fetal growth restriction, abnormal Doppler studies, and abnormal placental morphology. These pregnancies had increased incidence of preterm birth <34<sup>0</sup> weeks (52/132; 39.3%), preeclampsia (69/132; 52.3%), neonatal intensive care unit admission (54/132; 40.9%), and small-for-gestational-age neonates (15/132; 11.4%). Most negative predictive values exceeded 90%.</div></div><div><h3>Conclusions</h3><div>Low maternal PlGF levels are strongly associated with ultrasound and biochemical indicators of placental dysfunction and adverse perinatal outcomes. PlGF testing may serve as an effective risk stratification tool in high-risk pregnancies, particularly in rural and underserved populations.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 12","pages":"Article 103120"},"PeriodicalIF":2.2,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145056538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2025-09-11DOI: 10.1016/j.jogc.2025.103115
Catriona J. Buick RN, PhD, CON(C) , Akinkunle Oye-Somefun MSc, PhD , Charlotte Lee RN, OCN, CON(C), PhD , Allyson Nowell RN, MSc, CON(C) , Meagan Kennedy RN, MScN, PHC-NP , Parmis Mirzadeh MSc , Danielle Vicus MD, MSc
Objective
In Canada, gynaecologic cancers significantly impact adults aged 18–40 years, who may undergo multiple treatment modalities impacting their overall well-being. The objective of this study was to understand the individual characteristics, supportive care, and informational needs of these persons.
Methods
A cross-sectional survey of N = 50 adults (aged ≤40 years) receiving treatment (chemotherapy, surgery, and/or radiation) or under surveillance for gynaecologic cancer at a tertiary cancer centre in Toronto, Canada.
Results
Unmet supportive care needs were commonly reported, with more than half of the participants indicating unmet needs in all but 1 of the 5 domains (psychological [78%], health system and information [68%], physical and daily living [54%], sexuality [50%], and patient care and support [46%]). Unmet supportive care needs were associated with a host of psychosocial, demographic, and clinical factors. Notably, for psychosocial factors, low resilience was associated with a higher likelihood of unmet supportive care needs (health system and information [OR 2.97, 95% CI 1.06–8.35], physical and daily living [4.95, 1.69–22.66], and patient care and support [5.91, 1.77–40.50] domains and low perceived information and satisfaction [3.11, 1.30–11.60]). Various other socio-demographic (e.g., non-European cultural origins and other ethnicity, further distance to cancer centre) and clinical factors (e.g., number of treatment modalities) were also related to unmet needs.
Conclusion
Future studies must examine how to best meet the needs of younger adults affected by gynaecologic cancers to improve client-centred, supportive care through early intervention and adequate resources.
{"title":"Predictors of Supportive Care in Young Adults Diagnosed With a Gynaecologic Malignancy","authors":"Catriona J. Buick RN, PhD, CON(C) , Akinkunle Oye-Somefun MSc, PhD , Charlotte Lee RN, OCN, CON(C), PhD , Allyson Nowell RN, MSc, CON(C) , Meagan Kennedy RN, MScN, PHC-NP , Parmis Mirzadeh MSc , Danielle Vicus MD, MSc","doi":"10.1016/j.jogc.2025.103115","DOIUrl":"10.1016/j.jogc.2025.103115","url":null,"abstract":"<div><h3>Objective</h3><div>In Canada, gynaecologic cancers significantly impact adults aged 18–40 years, who may undergo multiple treatment modalities impacting their overall well-being. The objective of this study was to understand the individual characteristics, supportive care, and informational needs of these persons.</div></div><div><h3>Methods</h3><div>A cross-sectional survey of N = 50 adults (aged ≤40 years) receiving treatment (chemotherapy, surgery, and/or radiation) or under surveillance for gynaecologic cancer at a tertiary cancer centre in Toronto, Canada.</div></div><div><h3>Results</h3><div>Unmet supportive care needs were commonly reported, with more than half of the participants indicating unmet needs in all but 1 of the 5 domains (psychological [78%], health system and information [68%], physical and daily living [54%], sexuality [50%], and patient care and support [46%]). Unmet supportive care needs were associated with a host of psychosocial, demographic, and clinical factors. Notably, for psychosocial factors, low resilience was associated with a higher likelihood of unmet supportive care needs (health system and information [OR 2.97, 95% CI 1.06–8.35], physical and daily living [4.95, 1.69–22.66], and patient care and support [5.91, 1.77–40.50] domains and low perceived information and satisfaction [3.11, 1.30–11.60]). Various other socio-demographic (e.g., non-European cultural origins and other ethnicity, further distance to cancer centre) and clinical factors (e.g., number of treatment modalities) were also related to unmet needs.</div></div><div><h3>Conclusion</h3><div>Future studies must examine how to best meet the needs of younger adults affected by gynaecologic cancers to improve client-centred, supportive care through early intervention and adequate resources.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 11","pages":"Article 103115"},"PeriodicalIF":2.2,"publicationDate":"2025-09-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145058880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Medical disorders in pregnancy are increasing. This highlights the need for obstetrics trainees to develop a strong foundation in managing medical conditions in pregnancy.
Methods
To address this, the internal medicine curriculum at our institution was redesigned for first year obstetrics residents to include an obstetric medicine (OBM) rotation.
Results
Before implementation, only 19% of residents felt at least moderately comfortable with OBM topics outlined by the Canadian Consensus for a Curriculum in Obstetric Medicine. This increased to 66% after the introduction of the redesigned curriculum. Using quality improvement methodology, we aimed to increase this to 80% via iterative plan-do-study-act cycles. Post-intervention, 81% of trainees reported feeling at least moderately comfortable in 14 of 17 Canadian Consensus for a Curriculum in Obstetric Medicine topics.
Conclusions
This quality improvement–driven curriculum enhancement was well-received and further highlights the value of early OBM integration in obstetrics training.
{"title":"Evaluation of an Obstetric Medicine Curriculum for Obstetrics and Gynecology Trainees: A Quality Improvement Study","authors":"Kelsey MacEachern BMSc, MD , Katherine Steckham MD , Michelle Morais BSc, MD, DRCPSC , Serena Gundy MD , Amanda Huynh MD, MSc QIPS","doi":"10.1016/j.jogc.2025.103116","DOIUrl":"10.1016/j.jogc.2025.103116","url":null,"abstract":"<div><h3>Objectives</h3><div>Medical disorders in pregnancy are increasing. This highlights the need for obstetrics trainees to develop a strong foundation in managing medical conditions in pregnancy.</div></div><div><h3>Methods</h3><div>To address this, the internal medicine curriculum at our institution was redesigned for first year obstetrics residents to include an obstetric medicine (OBM) rotation.</div></div><div><h3>Results</h3><div>Before implementation, only 19% of residents felt at least moderately comfortable with OBM topics outlined by the Canadian Consensus for a Curriculum in Obstetric Medicine. This increased to 66% after the introduction of the redesigned curriculum. Using quality improvement methodology, we aimed to increase this to 80% via iterative plan-do-study-act cycles. Post-intervention, 81% of trainees reported feeling at least moderately comfortable in 14 of 17 Canadian Consensus for a Curriculum in Obstetric Medicine topics.</div></div><div><h3>Conclusions</h3><div>This quality improvement–driven curriculum enhancement was well-received and further highlights the value of early OBM integration in obstetrics training.</div></div>","PeriodicalId":16688,"journal":{"name":"Journal of obstetrics and gynaecology Canada","volume":"47 12","pages":"Article 103116"},"PeriodicalIF":2.2,"publicationDate":"2025-09-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145056534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}